Inhibition of SUV39H1 as a potent therapeutic target in multiple myeloma

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2026-04-16
DOI
https://doi.org/10.3324/haematol.2025.300333
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Inhibition of SUV39H1 as a potent therapeutic target in multiple myeloma

Julie Devin, Jérôme Moreaux, Caroline Bret, Sara Ovejero et al.
Haematologica
Multiple Myeloma Research and Treatments
article

Inhibition of SUV39H1 as a potent therapeutic target in multiple myeloma

Julie Devin, Jérôme Moreaux, Caroline Bret, Sara Ovejero, Laura Alibert, Guilhem Requirand, Laure Vincent, Giacomo Cavalli, Morgane Thomas, Matthieu Angles, Anne Marie Martinez, Guillaume Cartron, Charles Herbaux, Nicolas Robert, Alboukadel Kassambara
article en

Abstract

No abstract available for this paper.
Haematologica
Centre National de la Recherche Scientifique (FR), Université de Montpellier (FR), Centre Hospitalier Universitaire de Montpellier (FR), Montpellier GenomiX (FR), Institut de Génétique Moléculaire de Montpellier (FR), Institut Universitaire de Recherche Clinique (FR), Services déconcentrés d'appui à la recherche Occitanie-Montpellier (FR), Institut de Génétique Humaine (FR)
Openalex Percentile: Top 19%
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.